Corrao Mark
SEC-identified person · CIK 1634371 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Apimeds Pharmaceuticals US, Inc. APUS | Chief Financial Officer | filed 2025–2025 |
| Amesite Inc. AMST | Chief Financial Officer | filed 2022–2022 |
| TYG Solutions Corp. TYYG | Chief Financial Officer | filed 2018–2021 |
| Brain Scientific INC. BRSF | Chief Financial Officer | filed 2020–2020 |
| Generex Biotechnology Corp GNTB | CFO & Treasurer | filed 2018–2018 |
| America Resources Exploration Inc. AREN | CFO | filed 2015–2015 |
| Western Graphite Inc. WSGP | Director · CFO and Secretary | filed 2015–2015 |
| Success Holding Group International, INC. SHGT | Director | filed 2015–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.